NeoGenomics Inc (STU:NG9)
€ 12.6 -0.1 (-0.79%) Market Cap: 1.76 Bil Enterprise Value: 1.96 Bil PE Ratio: 0 PB Ratio: 1.97 GF Score: 76/100

Neogenomics Inc at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 06:20PM GMT
Release Date Price: €17 (+18.06%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Good morning, everyone. Welcome to Bank of America's 2023 Global Healthcare Conference coming live from Wynn Encore Hotel here in Las Vegas. I'm Derik De Bruin, you guys know me, and along my colleague, Mike Briskin, we cover the life sciences and diagnostics tools space. And our next company up is NeoGenomics. And with us today is CEO, Chris Smith; and Jeff?

Jeffrey S. Sherman
NeoGenomics, Inc. - CFO

Sherman.

Christopher Michael Smith
NeoGenomics, Inc. - CEO & Director

Before a user here, thank you. Good to meet all of you. (inaudible), sitting in the back.

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

My apologies, definitely I have a mental breakdown there for a minute, but thanks for being here. Thanks for coming in and doing this. You just reported Q1 results on Monday, -- good quarter. Stock responded nicely, good rebound in the business. Do you want to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot